# Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia

> **NCT00079885** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 430 (actual)

## Conditions studied

- Community Acquired Pneumonia
- Bacterial Pneumonia
- Cross Infection

## Interventions

- **DRUG:** tigecycline

## Key facts

- **NCT ID:** NCT00079885
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 430 (ACTUAL)
- **Last updated:** 2013-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00079885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00079885, "Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00079885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*